Rebrain services provide precise brain targeting for DBS neurosurgery, enhancing patient outcomes in Parkinson’s disease and Essential Tremor treatments

RebrAIn’s news

Back to Resources

MedTech Strategist Features RebrAIn’s Precision Targeting Solutions for Parkinson’s Disease

We are delighted to share that MedTech Strategist has featured RebrAIn in their latest issue.

The article explores how our supervised AI-driven platform, OptimMRI, simplifies precision targeting for Deep Brain Stimulation (DBS) in Parkinson’s Disease. By enhancing accuracy and reducing costs, RebrAIn aims to make DBS procedures faster, safer, and more accessible. Our innovative approach is set to transform neurosurgical practices, offering improved outcomes for patients.

Read more about our advancements and future plans in the full PDF version of the article.

Back to Resources

Our latest public updates

From Patient to Practice: RebrAIn Wins the Resah Tender

From Patient to Practice: RebrAIn Wins the Resah Tender

Mar 19, 2025

The Strategic Importance of This Tender This success marks a major strategic turning point for RebrAIn, as the Resah procurement center plays a key role in the public healthcare sector in France. By enabling the member hospitals to choose the most effective...

RebrAIn Hosts Inaugural Medical Advisory Board Meeting (MAB)

RebrAIn Hosts Inaugural Medical Advisory Board Meeting (MAB)

Oct 1, 2024

RebrAIn recently held the inaugural meeting of its Medical Advisory Board (MAB), marking a significant milestone in the company’s ongoing mission to deliver transformative AI-powered tools to neurosurgeons. The meeting also underscored RebrAIn's pivotal role in...